Autoimmune diseases constitute one of the most pressing global health challenges, affecting hundreds of millions of individuals and encompassing more than ...

A study has revealed how the Epstein-Barr virus triggers T-cell responses that may drive autoimmunity in MS patients.

InnoCare Pharma (HKEX: 09969; SSE: 688428), today announced that the Journal of Autoimmunity has published results from a clinical study evaluating orelabrutinib, a BTK (Bruton’s tyrosine kinase) ...

Patterns differ among medication classes; potential mechanisms need more research ...

Confirming multiple sclerosis used to take years, and at the time, there were no treatments to slow the disease’s progression ...

Is your ‘good girl’ addiction making you sick? Mine gave me an autoimmune disease - FIRST PERSON: After being diagnosed with ...

Bone spurs themselves usually don’t cause pain—heel pain is far more often due to plantar fasciosis, poor footwear, and ...

Treatment with investigational DNASE1L3 analog NTR-441, which degrades neutrophil extracellular traps (NETs), resulted in rapid clinical improvement in a patient with treatment-refractory SLE ...

Cancer immunotherapy has revolutionized oncology, with immune checkpoint inhibitors (ICIs) becoming integral components of modern anti-cancer treatment ...

Incyte (Nasdaq: INCY) today announced complete safety and efficacy data from all patients (n=16) enrolled in the Phase 1/2 multidose study of VGA039 (latarcibart), a novel, Protein S-targeting, ...

Instead, the seemingly botched experiment helped launch a new generation of therapies for autoimmune diseases afflicting ...